4
8
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T76978 |
Siltuximab
CNTO-328 |
IL Receptor | Immunology/Inflammation |
Siltuximab(CNTO-328) 是一种靶向 IL-6 且具有抗肿瘤活性的单克隆抗体,可用于研究巨大淋巴结增生症 (MCD) 和 COVID-19。 | |||
T40950 | A3334 | ||
A3051, is a robust and orally active inhibitor of CXXC5-DVL with an IC 50 of 63.06 nM. Its applications include research into phenotypes associated with obesity, diabetes, and NASH that are induced by high fat diet (HFD) and methionine-choline deficient diet (MCD). | |||
T37405 |
Octanoyl Coenzyme A (sodium salt)
|
||
Octanoyl coenzyme A (octanoyl-CoA) is a medium-chain acyl CoA and a metabolic intermediate in mitochondrial fatty acid β-oxidation. Levels of octanoyl-CoA are increased in the liver of patients with Reye's syndrome and β-oxidation of octanoyl-CoA by medium-chain acyl CoA dehydrogenase (MCADH) is decreased in patients with MCADH deficiency (MCD). Octanoyl-CoA inhibits citrate synthase and glutamate dehydrogenase. | |||
T79454 | Anti-NASH agent 1 | PPAR | DNA Damage/DNA Repair; Metabolism |
Anti-NASH agent 1 (compound 3d),Elafibranor衍生物,高效PPAR-α/δ激动剂,针对非酒精性脂肪性肝炎(NASH)。以3-10 mg/kg剂量,连续4周处理,能显著改善蛋氨酸胆碱缺乏(MCD)诱导的NASH小鼠高脂血症、肝脏脂肪变性及炎症状况,展现出低肝毒性和良好肝脏保护效能。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-02005 |
Mucin-1/MUC1 Protein, Human, Recombinant (hFc)
PEM,ADMCKD1,CA15-3,CD227,MCD,mucin 1, cell surface ... |
Human | HEK293 Cells |
Mucin-1/MUC1 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 42 kDa and the accession number is P15941-11. | |||
TMPY-04340 |
Mucin-1/MUC1 Protein, Human, Recombinant
mucin 1, cell surface associated,MUC-1/SEC,PEM,MUC1/ZD,MUC-1... |
Human | HEK293 Cells |
Mucin-1/MUC1 Protein, Human, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 15.4 kDa and the accession number is P15941-11. | |||
TMPY-06833 |
Mucin-1/MUC1 Protein, Human, Recombinant (aa 890-1158, His)
MUC1/ZD,MUC-1,MUC-1/SEC,CA15-3,mucin 1, cell surface associa... |
Human | HEK293 Cells |
Mucin-1/MUC1 Protein, Human, Recombinant (aa 890-1158, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 29.28 kDa and the accession number is P15941-1. | |||
TMPY-06832 |
Mucin-1/MUC1 Protein, Human, Recombinant (aa 1-380, His)
PEM,MUC-1,EMA,H23AG,Mucin 1,PEMT,mucin 1, cell surface assoc... |
Human | HEK293 Cells |
Mucin-1/MUC1 Protein, Human, Recombinant (aa 1-380, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 35.19 kDa and the accession number is P15941-1. | |||
TMPY-06707 |
Mucin-1/MUC1 Protein, Human, Recombinant (aa 1-173, His)
ADMCKD,PEMT,KL-6,ADMCKD1,H23AG,mucin 1, cell surface associa... |
Human | HEK293 Cells |
Mucin-1/MUC1 Protein, Human, Recombinant (aa 1-173, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 17.49 kDa and the accession number is P15941-8. | |||
TMPY-02871 |
Mucin-1/MUC1 Protein, Human, Recombinant (mFc)
mucin 1, cell surface associated,ADMCKD1,EMA,MCKD1,Mucin 1,M... |
Human | HEK293 Cells |
Mucin-1/MUC1 Protein, Human, Recombinant (mFc) is expressed in HEK293 mammalian cells with mFc tag. The predicted molecular weight is 41 kDa and the accession number is P15941-11. | |||
TMPJ-01364 |
LMCD1 Protein, Human, Recombinant (His)
LMCD1,Dyxin,LIM and cysteine-rich domains protein 1 |
Human | E. coli |
LMCD1 is transcriptional cofactor which contains a cysteine-rich domain in the N-terminal region and 2 LIM domains in the C-terminal region. It also has several potential phosphorylation and N-myristoylation sites and a single potential N-glycosylation site. LMCD1 is expressed in many tissues with highest abundance in skeletal muscle. LMCD1 restricts GATA6 function by inhibiting DNA-binding, resulting in repression of GATA6 transcriptional activation of downstream target genes. It plays a critic... | |||
TMPH-01634 |
MLYCD Protein, Human, Recombinant (His & Myc)
|
Human | E. coli |
Catalyzes the conversion of malonyl-CoA to acetyl-CoA. In the fatty acid biosynthesis MCD selectively removes malonyl-CoA and thus assures that methyl-malonyl-CoA is the only chain elongating substrate for fatty acid synthase and that fatty acids with multiple methyl side chains are produced. In peroxisomes it may be involved in degrading intraperoxisomal malonyl-CoA, which is generated by the peroxisomal beta-oxidation of odd chain-length dicarboxylic fatty acids. Plays a role in the metabolic ... |